Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia

Clinical trial NCT02234752 · TERMINATED

Trial details

NCT number: NCT02234752
Sponsor: Sheppard Pratt Health System
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2014-09-01
Primary completion: 2016-07-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.